LHC Pharma
Established Pretoria · 2012

Healthcare for all species.Across one shared ecosystem.

LHC Pharmaceuticals is a registered South African pharmaceutical manufacturer specialising in generic, biosimilar, and innovative medicines, with NEHAWU Investment Holdings as its shareholder. Anchored by an exclusive strategic partnership with KRKA across Southern Africa, LHC stands as one of the largest Black-owned pharmaceutical companies registered with SAHPRA, holding the region's most substantial Black-owned SAHPRA dossier portfolio.

Est. 2012ZA · 01LHC Pharmaceuticals

One Health – One Ecosystem

SAHPRALicensed Marketing Authorisation Holder
70+Registered SAHPRA product lines
R100M+NDoH tender awarded 2026
2012Founded in Pretoria
SAHPRA-licensed MAHEstablished 201270+ SAHPRA product linesKRKA Platinum partnerNDoH 2026 tender awarded

What we do

Three ways we move medicine from manufacturer to community.

Illustrated icon representing dossier ownership.
01

Own

We hold our own dossiers. LHC has registered more than seventy product lines with SAHPRA, from generic statins and antibiotics to specialised therapies for malaria, tuberculosis, and HIV. Twenty-five more dossiers are in active review.

Illustrated icon representing distribution across southern Africa.
02

Distribute

We move medicine across eight countries. Through a curated channel network of pharmacies and wholesalers, our products reach communities from Pretoria to Luanda to Juba, without the cost or opacity of long intermediary chains.

Illustrated icon representing retail handover to the patient.
03

Retail

We close the loop with the patient. Our partnerships with Medipost, Spar Pharmacies, Ekhaya, and other community-rooted retailers put quality medicine within reach of every household we serve.

Footprint

From Pretoria to the rest of southern Africa.

Six markets, with a local partner in each. We don't ship through faceless intermediaries. Every country we operate in has a partner pharmacy, wholesaler, or distributor whose name we can tell you. Specificity is how trust gets built.

6countries served
Map of Africa highlighting the six countries LHC Pharmaceuticals serves: South Africa, Namibia, Botswana, Zimbabwe, Zambia, and Mozambique.

Working with

Trusted partners in manufacturing, distribution, and retail.

Strategic & equity

KRKA d.d. (Slovenia)
Macleods (India)
VS International
CSIR
Alveta

Channel partners

Dis-Chem
Clicks
Medirite
Kalapeng Spar Pharmacies
Arrie Nel Pharmacies
City Medical

Our story

Built by a doctor and a pharmacist who didn't see the medicine reaching the people who needed it.

LHC was founded in 2012 by a registered medical practitioner and a pharmacist. They began with a clinical observation, that quality medicine was reaching urban centres but not the communities they trained to serve, and built backward from there. First retail in 2006. Then wholesale and distribution in 2009. Then registration as a SAHPRA Marketing Authorisation Holder in 2012, holding dossiers sourced from reputable manufacturers worldwide. Today LHC is the result of that "end-to-the-beginning" approach: a company that understands the supply chain because it has stood at every point of it.

The work so far

Twenty years of moving medicine, deliberately.

2012

Year founded, Pretoria, South Africa

0

SADC countries with active distribution

0+

Registered product lines

0+

Dossiers awaiting SAHPRA approval

Quality · Compliance · Care

Every product is registered. Every batch is traceable. Every claim is reviewed.

Regulatory dossier under review on a wooden desk, soft window light from the left.

SAHPRA registered

Every product we distribute in South Africa is registered with the South African Health Products Regulatory Authority. Our pending dossiers, currently more than twenty-five, are tracked publicly through SAHPRA's submission system.

Internationally manufactured

Our flagship contract manufacturing partner is KRKA in Slovenia, whose products are registered in dozens of jurisdictions worldwide. Where KRKA does not manufacture for us, we work with comparably accredited European partners.

Linezolid Fast-Track

Our Linezolid LHC application received Fast-Track status from the regulator, a measure of our submission quality and the public-health value of the molecule for tuberculosis treatment in Southern Africa.

Healthy life for all — partner with us.

If you're a pharmacy, wholesaler, healthcare professional, or investor, we'd like to hear from you.